RARE DISEASE DAY 2023

By the numbers, there are currently 300 million people living with one of over 6,000 rare diseases worldwide. These affect between 3.5 and 5.9% of the population. 72% of rare diseases are genetic and 70% start in childhood. There is no cure for the majority of diseases and a few treatments available.

By the numbers, there are currently 300 million people living with one of over 6,000 rare diseases worldwide. These affect between 3.5 and 5.9% of the population. 72% of rare diseases are genetic and 70% start in childhood. There is no cure for the majority of diseases and a few treatments available.
February 28, 2023

Rare Disease Day is a globally-coordinated movement on rare diseases, working towards equity in social opportunity, healthcare, and access to diagnosis and therapies for people living with a rare disease. A disease is rare when it affects fewer than 1 in 2,000 people and people with a rare disease face several challenges, such as: lack of scientific knowledge, quality information, initial misdiagnosis, etc.

At Asphalion we would like to highlight our commitment to helping the development of new treatments for rare diseases. Our Scientific and Regulatory Affairs team contributes with its knowledge and expertise in supporting organizations throughout the regulatory pathway to obtain the Orphan Drug Designation in EU and US. This status provides benefits for a fee reduction or exemption, protocol assistance, access to research grants and 10-year EU market exclusivity (after authorization). So far, our experts have participated in over 50 projects related to successful Orphan Drug Designations.

We actively contribute to bringing treatments to the market and thus improving patient´s lives, and today is a day to raise awareness and improve access to treatment for those individuals with rare diseases.

For further information, you can contact us at: info@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

NEW | User Acceptance Testing (UAT) phase

Asphalion Expert Beatriz Ugalde Dionicio has been selected by the European Medicines Agency (EMA) to participate in the Product Management Service (PMS) Product User Interface

NEW | CTIS EMA Subject Matter Expert

At Asphalion we are very proud to announce that Nuria Garcia Pazos has been appointed EMA Subject Matter Expert (SME) for Clinical Trials Information System

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting